Endovascular Engineering Raises $42 Million in Series B Financing to Advance the Treatment of Pulmonary Embolism Endovascular EngineeringChristine JohnsonFebruary 20, 2025
Endovascular Engineering Presents Positive Results from ENGULF Feasibility Trial with its Hēlo™ PE Thrombectomy System for the Treatment of Pulmonary Embolism Endovascular EngineeringChristine JohnsonMay 6, 2024
Endovascular Engineering Appoints Dan Rose as Chief Executive Officer Endovascular EngineeringChristine JohnsonApril 20, 2024
